Rabourn Amy Zaremba - 18 Jan 2024 Form 4 Insider Report for Ocuphire Pharma, Inc. (IRD)

Role
SVP of Finance
Signature
/s/ Emily Johns, by Power of Attorney
Issuer symbol
IRD
Transactions as of
18 Jan 2024
Net transactions value
$0
Form type
4
Filing time
22 Jan 2024, 18:01:02 UTC
Previous filing
12 Jan 2024
Next filing
06 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCUP Common Stock Award $0 +40,000 +94% $0.000000 82,658 18 Jan 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCUP Employee Stock Option (right to buy) Award $0 +60,000 $0.000000 60,000 18 Jan 2024 Common Stock 60,000 $2.77 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of January 18, 2024.
F2 The option will vest with respect to 15,000 shares on January 18, 2025, with the balance vesting quarterly in twelve equal installments thereafter at the end of each quarter.